Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
10 - Substance Use and Impulsive Compulsive Disorders and their Treatment
Published online by Cambridge University Press: 19 October 2021
Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Stahl's Self-Assessment Examination in PsychiatryMultiple Choice Questions for Clinicians, pp. 351 - 379Publisher: Cambridge University PressPrint publication year: 2019
References
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.1Google Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.2Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.1Google Scholar
References
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.1Google Scholar
References
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.1Google Scholar
Stice, E, Gau, JM, Rohde, P, Shaw, H. Risk factors that predict future onset of each DSM-5 eating disorder. Predictive specificity in high-risk adolescent females. J Abnorm Psychol 2017;126(1):38–51.2Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.1Google Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.1Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.1Google Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.2Google Scholar
References
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.2CrossRefGoogle Scholar
References
Ambrogne, JA. Reduced-risk drinking as a treatment goal: what clinicians need to know. J Subst Abuse Treatment 2002;22(1):45–53.1CrossRefGoogle ScholarPubMed
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.2Google Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.3Google Scholar
References
Baumann, MH. Awash in a sea of ‘bath salts’: implications for biomedical research and public health. Addiction 2014;109(10):1577–9.1CrossRefGoogle Scholar
References
Loeffler, G, Hurst, D, Penn, A, Yung, K. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces. Milit Med 2012;177(9):1041–8.1Google Scholar
Seely, KA, Lapoint, J, Moran, JH, Fattore, L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Progr Neuropsychopharmacol Biol Psychiatry 2012;39(2):234–43.2Google Scholar
Woo, TM, Hanley, JR. “How high do they look?”: identification and treatment of common ingestions in adolescents. J Pediatr Health Care 2013;27: 135–44.3CrossRefGoogle ScholarPubMed
References
Maoz, A, Hicks, MJ, Vallabhjosula, S et al. Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter. Neuropsychopharmacology 2013;38: 2170–8.1Google Scholar
References
Chavoustie, S, Frost, M, Snyder, O et al. Buprenorphine implants in medical treatment of opioid addiction. Expert Rev Clin Pharmacol 2017; 10(8):799–807.1Google Scholar
Dodrill, CL, Helmer, DA, Kosten, TR. Prescription pain medication dependence. Am J Psychiatry 2011;168(5):466–71.2CrossRefGoogle ScholarPubMed
Stahl, SM, Grady, MM. Stahl’s illustrated substance use and impulsive disorders. New York, NY: Cambridge University Press; 2012.3Google Scholar
References
Lutter, M, Nestler, EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 2009;139(3):629–32.1Google Scholar
Monteleone, P, Piscitelli, F, Scognamiglio, P et al. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. J Clin Endocrinol Metab 2012;97:E917–24.2Google Scholar
Weygandt, M, Schaefer, A, Schienle, A, Haynes, JD. Diagnosing different binge-eating disorders based on reward-related brain activation patterns. Hum Brain Mapping 2012;33:2135–46.3Google Scholar